Pulmatrix Presentation Now Available for On-Demand Viewing

Company invites individual and institutional investors to login at VirtualInvestorConferences.com

LEXINGTON, Mass., Aug. 12, 2015 /CNW/ -- Pulmatrix, Inc., (NASDAQ: PULM), today announced that their August 6 presentation from Robert Clarke, Chief Executive Officer, is available for on-demand viewing at VirtualInvestorConferences.com. As part of the presentation, Mr. Clarke reviewed Pulmatrix's strategic plan and provided an update on the Company's pipeline of inhaled therapeutics based on their proprietary iSPERSE™ inhaled dry powder technology.

VIEW NOW: http://tinyurl.com/aug6-post

Pulmatrix's presentation will be available 24/7 for 90 days. Investors and advisors may view shareholder materials from the "virtual trade booth" for the next three weeks.

Learn more about the event: http://VirtualInvestorConferences.com

About Pulmatrix

Pulmatrix is a clinical stage biopharmaceutical company developing innovative inhaled therapies to address serious pulmonary disease using its patented iSPERSE™ technology. The Company's proprietary product pipeline is focused on advancing treatments for rare diseases, including PUR1900, an inhaled anti-fungal for patients with cystic fibrosis (CF), as well as PUR1500, an inhaled product for the treatment of idiopathic pulmonary fibrosis. In addition, Pulmatrix intends to pursue opportunities in major pulmonary diseases through collaborations, which includes PUR0200, a branded generic in clinical development for chronic obstructive pulmonary disease (COPD) in partnership with Mylan N.V. Pulmatrix's product candidates are based on iSPERSE™, its proprietary dry powder delivery platform, which seeks to improve therapeutic delivery to the lungs by maximizing local concentrations and reducing systemic side effects to improve patient outcomes.

About VirtualInvestorConferences.com

VirtualInvestorConferences.com, created by BetterInvesting (NAIC) and PR Newswire, has been the only monthly virtual investor conference series that provides an interactive forum for presenting companies to meet directly with investors using a graphically-enhanced online platform.

Designed to replicate the look and feel of location-based investor conferences, Virtual Investor Conferences unites PR Newswire's leading-edge online conferencing and investor communications capabilities with BetterInvesting's extensive retail investor audience network.

Logo - http://photos.prnewswire.com/prnh/20150812/257831LOGO

SOURCE Pulmatrix, Inc.

For further information: Investor Contact: Tom Baker, Direct: 617-532-0624, tbaker@pulmatrix.com; Media Contact: David Schull, Russo Partners, Direct: (858) 717-2310, David.Schull@russopartnersllc.com

Organization Profile

Pulmatrix, Inc.

More on this organization

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890